Paper Details 
Original Abstract of the Article :
The aim of this study is to evaluate the clinical parameters, acute-phase reactants, side effects, genetic mutations among colchicine-resistant Familial Mediterranean fever (FMF) patients who received anti-interleukin-1 (anti-IL-1) treatment. We also evaluate the quality of life and school attendanc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/1756-185X.13891

データ提供:米国国立医学図書館(NLM)

Quality of Life in Children with Colchicine-Resistant Familial Mediterranean Fever

This single-center study examines the impact of [anti-interleukin-1 (anti-IL-1)] treatment on [quality of life] in children with [colchicine-resistant familial Mediterranean fever (FMF)]. The study investigates the clinical parameters, [acute-phase reactants], [side effects], and [genetic mutations] in patients who received [anti-IL-1] treatment. The researchers also evaluate the [quality of life] and [school attendance] of these children in relation to [anti-IL-1] therapy.

Improving Quality of Life for Children with FMF

This study highlights the potential benefits of [anti-IL-1] treatment in improving the [quality of life] of children with [colchicine-resistant familial Mediterranean fever (FMF)]. The research indicates that [anti-IL-1] treatment can significantly impact [clinical parameters], [acute-phase reactants], and [side effects], leading to improved [quality of life] and increased [school attendance] in these children. This research provides valuable insights for managing [FMF] in pediatric patients.

Finding Solutions for Challenging Diseases

This study underscores the importance of finding effective treatments for challenging diseases like [FMF]. Just as a camel endures the harsh conditions of the desert, children with [FMF] face a constant struggle. This research provides a beacon of hope by demonstrating that [anti-IL-1] treatment can significantly improve the quality of life for these children, allowing them to thrive despite their condition.

Dr.Camel's Conclusion

This research highlights the significance of finding effective treatment options for children with [colchicine-resistant familial Mediterranean fever (FMF)]. The study's findings emphasize the potential of [anti-IL-1] treatment in improving the quality of life for these children, providing valuable insights for managing this complex disease.

Date :
  1. Date Completed 2021-06-08
  2. Date Revised 2021-06-08
Further Info :

Pubmed ID

32558310

DOI: Digital Object Identifier

10.1111/1756-185X.13891

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.